KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Incyte (INCY) EPS (Weighted Average and Diluted) (2016 - 2026)

Incyte filings provide 17 years of EPS (Weighted Average and Diluted) readings, the most recent being $1.47 for Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 83.75% year-over-year to $1.47, compared with a TTM value of $7.08 through Mar 2026, up 2732.0%, and an annual FY2025 reading of $6.41, up 4173.33% over the prior year.
  • EPS (Weighted Average and Diluted) hit $1.47 in Q1 2026 for Incyte, up from $1.46 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $2.11 in Q3 2025, with the low at -$2.04 in Q2 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.76 (2023), compared with a mean of $0.72.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 650.0% in 2024 against a maximum downside of 326.67% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.12 in 2022, then surged by 641.67% to $0.89 in 2023, then grew by 6.74% to $0.95 in 2024, then surged by 53.68% to $1.46 in 2025, then grew by 0.68% to $1.47 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $1.47, $1.46, and $2.11 for Q1 2026, Q4 2025, and Q3 2025 respectively.